Stocks Health care PVLA
NASDAQ · Health carePalvella Therapeutics, Inc. (PVLA)
It posted a net loss of $61.7M. At June 30, 2026 it held $187.8M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.
What Palvella Therapeutics, Inc. does
Palvella Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PVLA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$41.7M | -$3.71 | n/a |
| 2024 | n/a | -$17.4M | -$7.83 | n/a |
| 2023 | $42.8M | $18.7M | $2.17 | -$13.9M |
| 2022 | $25.9M | -$33.3M | -$0.45 | -$61M |
| 2021 | $31.4M | -$45.7M | -$0.71 | -$8.6M |
| 2020 | $29.3M | -$37.2M | -$0.68 | -$48.6M |
Latest SEC filings
What Palvella Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 4, 2026
- August 4, 2026Quarterly report 10-Q · period to June 30, 2026
- August 4, 2026
- August 3, 2026Passive stake (5% or more) SCHEDULE 13G
- July 29, 2026Passive stake (5% or more) SCHEDULE 13G
- July 14, 2026Other event 8-K
- June 30, 2026
- June 16, 2026
Questions about PVLA
What does Palvella Therapeutics, Inc. do?
Palvella Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PVLA.
Is Palvella Therapeutics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $61.7M.
When did Palvella Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 18, 2026.
Similar companies
Follow PVLA
Get an email when Palvella Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PVLA: get an email when it filesWhere the numbers come from
Financial figures are the values Palvella Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.